A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan

Annals of the American Thoracic Society

Volumn 11, Issue 1, 2014, Pages 1-8

  Morimoto, Kozo ^a   Iwai, Kazuro ^b   Uchimura, Kazuhiro ^b   Okumura, Masao ^a   Yoshiyama, Takashi ^a   Yoshimori, Kozo ^a   Ogata, Hideo ^a   Kurashima, Atsuyuki ^a   Gemma, Akihiko ^c   Kudoh, Shoji ^a  

^a Japan Anti Tuberculosis Association   (Japan)

^b FUKUJUJI HOSPITAL   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Epidemiology; Nontuberculous mycobacteria; Pulmonary

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIUM; DEATH; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; JAPAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MYCOBACTERIOSIS; NONTUBERCULOUS MYCOBACTERIOSIS; PATIENT CODING; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; SEX DIFFERENCE; STANDARDIZED MORTALITY RATIO; VITAL STATISTICS;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PREVALENCE; TUBERCULOSIS, PULMONARY;

EID: 84893484491     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201303-067OC     Document Type: Article

References (36)

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al.; ATS Mycobacterial Diseases Subcommittee, American Thoracic Society; Infectious Diseases Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416. (Pubitemid 46271561)
2. Okumura M, Iwai K, Ogata H, Ueyama M, Kubota M, Aoki M, Kokuto H, Tadokoro E, Uchiyama T, Saotome M, et al. Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 2008;47:1465-1472.
3. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009;49:e124-e129.
4. van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN, Boeree MJ, van Soolingen D. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 2009;64:502-506.
5. Andréjak C, Thomsen VØ, Johansen IS, Riis A, Benfield TL, Duhaut P, Sørensen HT, Lescure FX, Thomsen RW. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010;181:514-521.
6. Nontuberculous Mycobacteriosis Control Committee of the Japanese Society for Tuberculosis; Scientific Assembly for Infection and Tuberculosis of the Japanese Respiratory Society; International Exchanging Committee of the Japanese Society for Tuberculosis. Guidelines for the diagnosis of pulmonary nontuberculous mycobacterial diseases - 2008. Kekkaku 2011;86:37-39.
7. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Thorax 2000;55:210-218.
8. Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 2008;63:627-634. (Pubitemid 351969257)
9. Tsukamura M, Shimoide H, Kita N, Segawa J, Ito T. [A study on the frequency of "atypical" mycobacteria and of "atypical" mycobacterioses in Japanese national chest hospitals: report of the year 1971-1972] [in Japanese]. Kekkaku 1973;48:203-211.
10. Tsukamura M, Shimoide H, Kita N, Kawakami K, Ito T, Nakajima N, Kondo H, Yamamoto Y, Matsuda N, Tamura M, et al. Epidemiologic studies of lung disease due to mycobacteria other than Mycobacterium tuberculosis in Japan. Rev Infect Dis 1981;3:997-1007.
11. Sakatani M. [Nontuberculous mycobacteriosis (NTM) in Japan - epidemiologic and clinical study] [in Japanese]. Kekkaku 1994;69: 119-124.
12. Japan Anti-Tuberculosis Association. [Statistics of tuberculosis] [in Japanese]. Tokyo: Japanese Anti-Tuberculosis Association; 1998.
13. Satoh S. [Pulmonary nontuberculous mycobacterial diseases: an update] [in Japanese]. The Current Medicine 2008;56:317-324.
14. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010;182: 977-982.
15. Al-Houqani M, Jamieson F, Mehta M, Chedore P, May K, Marras TK. Aging, COPD, and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario. Chest 2012;141:190-197.
16. Morimoto K, Iwai K, Ohmori M, Okumura M, Yoshiyama T, Yoshimori K, Ogata H, Kurashima A, Kudoh S. [Nontuberculous mycobacteriosis mortality in Japan] [in Japanese]. Kekkaku 2011;86:547-552.
17. Statistics and Information Department, Ministry of Health, Labor, and Welfare. [Vital statistics of Japan] [in Japanese]. Tokyo: Ministry of Health, Labor, and Welfare; 2010. Available from: http://www.e-stat.go.jp/SG1/estat/ eStatTopPortal.do
18. Statistics Bureau of the Ministry of Internal Affairs and Communications. [National census results] [in Japanese]. Tokyo: Ministry of Internal Affairs and Communications; 2010. Available from: http://www.e-stat.go.jp/SG1/estat/ eStatTopPortal.do
19. Morrison AS. Sequential pathogenic components of rates. Am J Epidemiol 1979;109:709-718. (Pubitemid 10206315)
20. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-1021. (Pubitemid 36548927)
21. Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012;185:575-583.
22. Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: a NTM-NET collaborative study. Eur Respir J 2013;42:1604-1613.
23. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553-567.
24. Tsukamura M, Shimoide H, Kita N, Kawakami K, Yoshimoto I, Kuse A, Matusda N,Shirota N, Ito T, Kondo H, et al. [Studies on atypical mycobacteria and atypical mycobacterioses in Japan - report of the study year 1975-1976] [in Japanese]. Kekkaku 1978;53:65-72.
25. Kirschner RA Jr, Parker BC, Falkinham JO III. Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. Am Rev Respir Dis 1992;145:271-275.
26. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 2012;185:881-886.
27. Adjemian J, Olivier KN, Seitz AE, Falkinham JO III, Holland SM, Prevots DR. Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med 2012;186:553-558.
28. Falkinham JO III, Iseman MD, de Haas P, van Soolingen D. Mycobacterium avium in a shower linked to pulmonary disease. J Water Health 2008;6:209-213. (Pubitemid 351972136)
29. Maekawa K, Ito Y, Hirai T, Kubo T, Imai S, Tatsumi S, Fujita K, Takakura S, Niimi A, Iinuma Y, et al. Environmental risk factors for pulmonary Mycobacterium avium-intracellulare complex disease. Chest 2011;140:723-729.
30. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010;182:970-976.
31. Bodle EE, Cunningham JA, Della-Latta P, Schluger NW, Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis 2008;14:390-396. (Pubitemid 351451385)
32. Hernández-Garduño E, Rodrigues M, Elwood RK. The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada. Int J Tuberc Lung Dis 2009;13:1086-1093.
33. Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, Maugein J; French Mycobacteria Study Group. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006;28:1211-1215. (Pubitemid 44883858)
34. Gerogianni I, Papala M, Kostikas K, Petinaki E, Gourgoulianis KI. Epidemiology and clinical significance of mycobacterial respiratory infections in Central Greece. Int J Tuberc Lung Dis 2008;12:807-812. (Pubitemid 351976713)
35. Thomson RM; NTM Working Group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010;16:1576-1583.
36. Freeman J, Morris A, Blackmore T, Hammer D, Munroe S, McKnight L. Incidence of nontuberculous mycobacterial disease in New Zealand, 2004. N Z Med J 2007;120:U2580.